| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $118,882,188 ) (Continued on the next page) |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH128311 | A translational approach for novel mechanisms of epigenetic regulation in treatment responses: toward a precision medicine model | 000 | 5 | NIH | 1/29/2026 | $694,188 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH130532 | Neural and affective mechanisms underlying prospective self-control costs | 000 | 4 | NIH | 4/2/2026 | $601,710 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH140431 | Prenatal maternal brain plasticity and associations with maternal and infant neurobehavioral health | 000 | 1 | NIH | 3/5/2026 | $771,272 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH142698 | Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual Anhedonia | 000 | 1 | NIH | 2/19/2026 | $871,225 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH136353 | Dissection of noncoding repeats in psychiatric genetics using synthetic regulatory genomics - Resubmission | 000 | 2 | NIH | 12/31/2025 | $643,156 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL171292 | EHR Nudges: Optimizing a Clinical Decision Support System for Evidence-Based Statin Medication Prescribing to Reduce the Risk of Cardiovascular Disease | 000 | 3 | NIH | 4/6/2026 | $746,347 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL172365 | The role of immune-responsive gene 1 and itaconate in atherosclerotic disease | 000 | 3 | NIH | 4/8/2026 | $742,785 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL172335 | Long noncoding RNA regulation of Atherosclerotic Cardiovascular Disease | 000 | 3 | NIH | 3/27/2026 | $717,206 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL175155 | Defining targetable vulnerabilities in UBA1-mutated VEXAS HSCs for clonal eradication | 001 | 2 | NIH | 3/24/2026 | $22,883 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL175155 | Defining targetable vulnerabilities in UBA1-mutated VEXAS HSCs for clonal eradication | 000 | 2 | NIH | 2/26/2026 | $724,607 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH101377 | Deconstruction of a Neural Circuit for Aggression | 000 | 14 | NIH | 12/2/2025 | $746,458 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MD018597 | Enhancing Early Relational Health to Reduce Disparities in Child Health and Development: Addressing ACEs and Promoting PCEs through an Integrated Evidence-based Intervention in Pediatric Primary Care | 001 | 4 | NIH | 2/21/2026 | $83,300 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MD018597 | Enhancing Early Relational Health to Reduce Disparities in Child Health and Development: Addressing ACEs and Promoting PCEs through an Integrated Evidence-based Intervention in Pediatric Primary Care | 000 | 4 | NIH | 2/8/2026 | $749,702 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MD018520 | Partners IN CONTROL: Using Remote MonitorINg teChnology with cOmmuNity healTh woRkers to support hypertensiOn management patients at Federally QuaLified Health Centers | 000 | 4 | NIH | 1/12/2026 | $562,461 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MD018018 | Do no digital harm? A multilevel evaluation of technology-facilitated team care on the patient-provider relationship in health disparity populations | 000 | 4 | NIH | 2/22/2026 | $640,243 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01LM014085 | Novel Computational Methods for Microbiome Data Analysis in Longitudinal Study | 000 | 4 | NIH | 1/13/2026 | $381,375 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MD016402 | Telephone-based stress management to reduce blood pressure in Black women with hypertension in the Jackson Heart Study | 000 | 4 | NIH | 2/23/2026 | $716,297 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MD018520 | Partners IN CONTROL: Using Remote MonitorINg teChnology with cOmmuNity healTh woRkers to support hypertensiOn management patients at Federally QuaLified Health Centers | 001 | 4 | NIH | 2/22/2026 | $62,495 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R37CA289040 | Elucidating The Adaptive Role Of Serine Codons During Pancreatic Tumorigenesis | 000 | 3 | NIH | 1/15/2026 | $454,103 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R37CA252483 | A behavioral economic intervention for low-income smokers | 001 | 5 | NIH | 4/16/2026 | $69,595 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R37CA252483 | A behavioral economic intervention for low-income smokers | 000 | 5 | NIH | 12/11/2025 | $626,343 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R37CA244775 | Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancer | 001 | 7 | NIH | 4/16/2026 | $65,288 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R37CA244775 | Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancer | 000 | 7 | NIH | 1/28/2026 | $587,592 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R35GM136250 | Regulation of cell proliferation by CRL ubiquitin ligases | 000 | 7 | NIH | 4/3/2026 | $389,850 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R35GM134947 | Mechanisms of Human DNA Double-Strand Break Repair via Quantitative Single-Molecule Imaging | 000 | 7 | NIH | 4/2/2026 | $480,109 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R35GM139610 | Understanding the mechanistic role of genome stability pathways in regulating cell homeostasis | 000 | 6 | NIH | 2/17/2026 | $466,125 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R35GM144109 | Molecular Mechanisms of Ion Transport | 000 | 5 | NIH | 4/2/2026 | $703,425 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R35GM145359 | Mechanisms of bacterial RNA degradation | 000 | 5 | NIH | 4/9/2026 | $768,282 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R25NS125593 | Building Research Aspirations In Neurology | 000 | 4 | NIH | 1/15/2026 | $134,928 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R35GM122515 | Nuclear organization and its role in gene regulation | 000 | 10 | NIH | 4/3/2026 | $742,410 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R24OD037800 | Genomically rewritten and tailored humanized mouse models for various organ disorders | 001 | 2 | NIH | 4/15/2026 | $202,790 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R24OD037800 | Genomically rewritten and tailored humanized mouse models for various organ disorders | 000 | 2 | NIH | 2/19/2026 | $642,164 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21MH136644 | In vivo assessment of the mitochondrial complex I in subjects with schizophrenia | 000 | 2 | NIH | 1/21/2026 | $211,875 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21NS140565 | Understanding the Neuroanatomical Abnormalities of Repetitive Head Impacts | 000 | 2 | NIH | 12/31/2025 | $254,250 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21NS138944 | Development and Function of Medulla Tangential Neurons | 000 | 2 | NIH | 3/25/2026 | $254,250 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21NS146788 | Regulation of Dopamine Release and Locomotor Activity by Leptin | 000 | 1 | NIH | 1/29/2026 | $211,875 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21AI191646 | Perivascular macrophages control the severity of experimental autoimmune encephalomyelitis | 000 | 1 | NIH | 2/3/2026 | $466,125 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21AI196870 | The role of CD69 in established resident memory T cells | 000 | 1 | NIH | 1/29/2026 | $466,125 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21CA292032 | Novel biologic therapeutics targeting vacuolar ATPase localized on plasma membrane | 001 | 2 | NIH | 4/16/2026 | $19,809 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21CA292032 | Novel biologic therapeutics targeting vacuolar ATPase localized on plasma membrane | 000 | 2 | NIH | 1/8/2026 | $178,294 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21CA297650 | DISSECTING THE ROLE OF THE IMMUNE MICROENVIRONMENT IN MELANOMA BONE METASTASIS | 001 | 2 | NIH | 4/16/2026 | $23,773 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21CA297650 | DISSECTING THE ROLE OF THE IMMUNE MICROENVIRONMENT IN MELANOMA BONE METASTASIS | 000 | 2 | NIH | 1/2/2026 | $213,951 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U24ES038377 | The NYU-Sage NAMs Data Hub and Coordinating Center: Harmonizing, Analyzing, and Disseminating New-Approach-Methodologies Data | 000 | 1 | NIH | 2/16/2026 | $5,000,000 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01DA063565 | Neurobehavioral Mechanisms of Social Behavior and Familial Structure | 000 | 1 | NIH | 3/9/2026 | $1,240,576 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01DK135012 | Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes- NYU Clinical Center | 000 | 4 | NIH | 3/4/2026 | $780,219 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01AG088351 | Age related loss of immune resilience during response to severe respiratory viral infections | 000 | 3 | NIH | 4/9/2026 | $510,636 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R61AG090384 | Off-the-shelf CAR-Engineered Macrophage Therapy for Alzheimer’s Disease | 001 | 2 | NIH | 2/26/2026 | $80,571 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R61AG090384 | Off-the-shelf CAR-Engineered Macrophage Therapy for Alzheimer’s Disease | 000 | 2 | NIH | 1/28/2026 | $725,149 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R35GM156624 | Elucidating mechanisms of spermatogonial stem cell competition | 001 | 2 | NIH | 3/19/2026 | $42,375 |
|
